BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12923277)

  • 21. Malignancies and cyclophosphamide exposure in Wegener's granulomatosis.
    Bernatsky S; Ramsey-Goldman R; Clarke AE
    J Rheumatol; 2008 Jan; 35(1):11-3. PubMed ID: 18176988
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?
    Sneller MC
    Arthritis Rheum; 2005 Jan; 52(1):1-5. PubMed ID: 15641069
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-tuberculosis treatment and infliximab.
    Wallis RS
    Respir Med; 2005 Dec; 99(12):1620-2. PubMed ID: 16039841
    [No Abstract]   [Full Text] [Related]  

  • 25. Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?
    Wong CF
    J Clin Rheumatol; 2008 Apr; 14(2):61-4. PubMed ID: 18391671
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory vertebral sarcoidosis responding to infliximab.
    Garg S; Garg K; Altaf M; Magaldi JA
    J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infliximab efficiency and failure.
    Rozin AP
    Ann Rheum Dis; 2004 Jun; 63(6):751-2; author reply 752. PubMed ID: 15140791
    [No Abstract]   [Full Text] [Related]  

  • 28. Wegener's granulomatosis presenting as unilateral parotid enlargement.
    Chegar BE; Kelley RT
    Laryngoscope; 2004 Oct; 114(10):1730-3. PubMed ID: 15454762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of rituximab in Wegener's granulomatosis: comment on the article by Wong.
    Sánchez-Cano D; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
    Nephrol Dial Transplant; 2007 Mar; 22(3):958-9; author reply 959. PubMed ID: 17237478
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

  • 31. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.
    Cazabon S; Over K; Butcher J
    Eye (Lond); 2005 Feb; 19(2):222-4. PubMed ID: 15258602
    [No Abstract]   [Full Text] [Related]  

  • 32. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis.
    Hammoudeh M
    Rheumatology (Oxford); 2006 Mar; 45(3):357-9. PubMed ID: 16368727
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.
    Mpofu S; Estrach C; Curtis J; Moots RJ
    Rheumatology (Oxford); 2003 Sep; 42(9):1117-8. PubMed ID: 12923271
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacillus calmette-guérin vaccination in a patient treated with infliximab.
    Toussirot E; Wendling D
    J Rheumatol; 2005 Dec; 32(12):2500-1. PubMed ID: 16331800
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 37. Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?
    Della Rossa A; Tavoni A; Merlini G; Baldini C; Sebastiani M; Lombardi M; Neglia D; Bombardieri S
    Rheumatology (Oxford); 2005 Aug; 44(8):1074-5. PubMed ID: 15840604
    [No Abstract]   [Full Text] [Related]  

  • 38. [Up-date on the use of infliximab in dermatology. Introduction].
    Sánchez-Carazo J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment options for refractory Wegener's granulomatosis: a role for rituximab?
    Antoniu SA
    Curr Opin Investig Drugs; 2007 Nov; 8(11):927-32. PubMed ID: 17979026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G; Velken M; Johnsen V
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.